Legato Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-34,444
Closed -$445K 613
2024
Q1
$445K Hold
34,444
0.05% 460
2023
Q4
$399K Hold
34,444
0.05% 458
2023
Q3
$440K Sell
34,444
-54,838
-61% -$777K 0.06% 427
2023
Q2
$1.22M Sell
89,282
-11,879
-12% -$170K 0.17% 204
2023
Q1
$1.55M Buy
101,161
+65,355
+183% +$999K 0.28% 105
2022
Q4
$480K Buy
+35,806
New +$480K 0.09% 354

Other funds holding PAHC

Legato Capital Management's PAHC Position: Q2 2024 in Review

Legato Capital Management sold out of Phibro Animal Health (PAHC) in Q2 2024, closing a stake of 34,444 shares — an estimated $445K sold.

Legato Capital Management first reported a position in PAHC in Q4 2022 and held it in 6 quarters. The position peaked at $1.55M in Q1 2023. 141 funds tracked by Wall St. Rank hold PAHC as of Q2 2024.

  • Legato Capital Management reported no remaining Phibro Animal Health position as of Q2 2024 after selling out during the quarter.
  • Legato Capital Management sold 34,444 Phibro Animal Health shares in Q2 2024, an estimated $445K.
  • Legato Capital Management first reported a position in Phibro Animal Health in Q4 2022 and held it in 6 quarters.
  • Legato Capital Management's Phibro Animal Health position peaked at $1.55M in Q1 2023.
  • 141 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2024.

Based on Legato Capital Management's 13F filing for Q2 2024, filed 26 Jul 2024.